Neurological manifestations due to COVID-19. Case report at Hospital Militar Central Bogotá, Colombia, and literature review

Manifestaciones neurológicas por COVID-19. Reporte de casos en Hospital Militar Central Bogotá, Colombia, y revisión de la literatura;
Manifestações neurológicas pela COVID-19. Relato de casos no Hospital Militar Central Bogotá, Colômbia, e revisão da literatura

dc.creatorLancheros Pineda, Lina María
dc.creatorYasno Arias , Diana Alejandra
dc.creatorZea Rojas , Diana Isabel
dc.creatorTorres Ballesteros, Viviana
dc.creatorBernal Pacheco, Oscar
dc.date2021-12-31
dc.date.accessioned2022-12-15T18:29:14Z
dc.date.available2022-12-15T18:29:14Z
dc.identifierhttps://revistas.unimilitar.edu.co/index.php/rmed/article/view/5144
dc.identifier10.18359/rmed.5144
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5357504
dc.descriptionAccording to the epidemiological sources of the World Health Organization, in the last decade, among the leading causes of mortality, more than 55 % resulted from non-communicable diseases, predominating cardiac ischemia, and stroke as the leading causes. In 2019, with the appearance of the new coronavirus, COVID-19, as an etiology of the pandemic that has impacted health, economy, and society, the familiar figures of the mortality curve have changed, not only because of the direct effect of the disease on multiple organs, but also because of the indirect effects, concerning lack of access to medical care in chronic diseases. Since it is a communicable disease, COVID-19 produces alterations, mainly respiratory and vascular; however, the greater knowledge of the patho- physiological aspects of the disease has revealed the involvement of multiple systems, highlighting the central nervous system as a target of the virus that impacts on the sequelae and outcomes of patients, so neurological manifestations are documented up to 55 %. The objective of this review is to characterize a series of cases of patients in Hospital Militar Central, by the description of pathophysi- ological and clinical aspects of the neurological compromise.en-US
dc.descriptionAcorde a las fuentes epidemiológicas de la Organización Mundial de la Salud, en la última década, entre las principales causas de mortalidad más del 55 % resultaban de enfermedades no transmisibles, predominando la isquemia cardiaca y el accidente cerebrovascular como causales. En el 2019, con la aparición del nuevo coronavirus, COVID-19, como etiología de la pandemia que ha impactado tanto en salud como económica y socialmente al mundo, las cifras de la curva de las causas usuales de mortalidad han cambiado no solo a causa del efecto directo de la enfermedad en los múltiples órganos, sino también por los efectos indirectos en relación con falta de acceso a atención médica en enfermedades crónicas. Dado que es una enfermedad transmisible, el COVID-19 produce alteraciones, principalmente respiratorias y vasculares, sin embargo, el mayor conocimiento de los aspectos fisiopatológicos de la enfermedad ha revelado el compromiso de múltiples sistemas, destacando el sistema nervioso central como un objetivo del virus que impacta en las secuelas y los desenlaces de los pacientes, de modo que se documentan manifestaciones neurológicas hasta en un 55 %. El objetivo de esta revisión es caracterizar una serie de casos de pacientes en el Hospital Militar Central, mediante la descripción de aspectos fisiopatológicos y clínicos del compromiso neurológicoes-ES
dc.descriptionDe acordo com fontes epidemiológicas da Organização Mundial da Saúde, na última déca- da, entre as principais causas de mortalidade, mais de 55 % resultavam de doenças não transmissíveis, com predominância da isquemia cardíaca e do acidente cerebrovascular como causais. Em 2019, com o surgimento no novo coronavírus (COVID-19), como etiologia da pandemia que vem impactando tanto em saúde quanto econômica e socialmente o mundo inteiro, as cifras da curva das causas usuais de mortalidade vêm mudando não somente devido ao efeito direto da doença nos múltiplos órgãos, mas também aos efeitos indiretos com relação à falta de acesso à atenção médica em doenças crônicas. Tendo em vista que é uma doença transmissível, a COVID-19 produz alterações principalmente respiratórias e vasculares, contudo o maior conhecimento dos aspectos fisiopatológicos da doença revela o comprometimento de vários sistemas, destacando o nervoso central como um objetivo do vírus, que impacta nas sequelas e nos desenlaces dos pacientes, de modo que são registradas manifestações neurológicas de até 55 %. O objetivo desta revisão é caracterizar uma série de casos de pacientes no Hospital Militar Central, mediante a descrição de aspectos fisiopa- tológicos e clínicos do comprometimento neurológico.pt-BR
dc.formatapplication/pdf
dc.formattext/xml
dc.languagespa
dc.publisherUniversidad Militar Nueva Granadaes-ES
dc.relationhttps://revistas.unimilitar.edu.co/index.php/rmed/article/view/5144/5011
dc.relationhttps://revistas.unimilitar.edu.co/index.php/rmed/article/view/5144/5070
dc.relation/*ref*/Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the mirac. J Med Virol. 2020;92(4):401-2. DOI: https://doi.org/10.1002/jmv.25678
dc.relation/*ref*/Chen N, Zhou M, Dong X, Qu J, Gong, F., Han Y, et al. Epidemiological and clinical characteristics of 99 cases
dc.relation/*ref*/of 2019 novel coronavirus pneumonia in Wuhan, Chi- na: a descriptive study. Lancet. 2020;395(10223):507- 13. DOI: https://doi.org/10.1016/S0140-6736(20)30211-7
dc.relation/*ref*/Papa SM, Brundin P, Fung VSC, Kang UJ, Burn DJ, Colosimo C, et al. Impact of the covid-19 Pandemic on Parkinson's Disease and Movement Disorders. Mov Disord. 2020;35(5):711-5. DOI: https://doi.org/10.1002/mds.28067
dc.relation/*ref*/Lippi A, Domingues R, Setz C, Outeiro TF, Krisko A. SARS-CoV-2: At the Crossroad Between Aging and Neurodegeneration. Mov Disord. 2020;35(5):716-20. DOI: https://doi.org/10.1002/mds.28084
dc.relation/*ref*/Costello F, Dalakas MC. Cranial Neuropathies and covid-19: Neurotropism and Autoimmunity. Neurology. 2020;95(5):195-6. DOI: https://doi.org/10.1212/WNL.0000000000009921
dc.relation/*ref*/Ahmed MU, Hanif M, Ali MJ, Haider MA, Khe- rani D, Memon GM, et al. Neurological Manifes- tations of covid-19 (sars-cov-2): A Review. Front Neurol. 2020;11:518. DOI: https://doi.org/10.3389/fneur.2020.00518
dc.relation/*ref*/Avula A, Nalleballe K, Narula N, Sapozhnikov S, Dan- du V, Toom S, et al. covid-19 presenting as stroke. Brain Behav Immune. 2020;87:115-119. DOI: https://doi.org/10.1016/j.bbi.2020.04.077
dc.relation/*ref*/Khosravani H, Rajendram P, Notario L, Chapman MG, Menon BK. Protected Code Stroke: Hyperacute Stroke Management during the Coronavirus Disease 2019 (covid-19) Pandemic. Stroke. 2020;51(6):1891-1895. DOI: https://doi.org/10.1161/STROKEAHA.120.029838
dc.relation/*ref*/Nguyen TN, Abdalkader M, Jovin TG, Nogueira R, Jadahav A, Hausse D, et al. Mechanical Thrombectomy in the Era of the covid-19 Pandemic: Emergency Preparedness for Neuroscience Teams: A Guidance Statement From the Society of Vascular and Interventional Neurology. Stroke. 2020;51(6):1896-901. DOI: https://doi.org/10.1161/STROKEAHA.120.030629
dc.relation/*ref*/Romoli M, Jelcic I, Bernard-Valnet R, García Azorín D, Mancinelli L, Akhvlediani T, et al. A Systematic Review of Neurological Manifestations of SARS-CoV-2 Infection: The Devil is Hidden in the Details. Eur J Neurol. 2020;10:1111.
dc.relation/*ref*/Reddy ST, Reddy ST, Garg T, Shah C, Nascimento FA, Imran R, et al. Cerebrovascular Disease in Patients with covid-19: A Review of the Literature and Case Series. Case Rep Neurol. 2020;12(2):199-209. DOI: https://doi.org/10.1159/000508958
dc.relation/*ref*/Benussi A, Pilotto A, Premi E, Libri I, Giunta M, Agosti C, et al. Clinical Characteristics and Outcomes of
dc.relation/*ref*/Manifestaciones neurológicas por covid-19. Reporte de casos en Hospital Militar Central Bogotá, Colombia, y revisión de la literatura inpatients with neurologic disease and covid-19 in Brescia, Lombardy, Italy. Neurology. 2020;10:1212. DOI: https://doi.org/10.1212/WNL.0000000000009848
dc.relation/*ref*/Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K, et al. sars-cov-2 and Stroke in a New York Healthcare System. Stroke. 2020;51(7):2002-11. DOI: https://doi.org/10.1161/STROKEAHA.120.030335
dc.relation/*ref*/Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):1-9. DOI: https://doi.org/10.1001/jamaneurol.2020.1127
dc.relation/*ref*/Beyrouti R, Adams ME, Benjamin L et al. Characteristics of ischaemic stroke associated with covid-19. J Neurol Neurosurg Psychiatry. 2020;91:889-91. DOI: https://doi.org/10.1136/jnnp-2020-323586
dc.relation/*ref*/Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of covid-19. Lancet Neurol. 2020;19(9):767-83. DOI: https://doi.org/10.1016/S1474-4422(20)30221-0
dc.relation/*ref*/WangL,ShenY,LiM,ChuangH,YeY,ZhaoH,etal. Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-Cov-2: a systematic review and meta-analysis. J Neurol. 2020;11:1-13. DOI: https://doi.org/10.1007/s00415-020-09974-2
dc.relation/*ref*/Payus AO, Lin CLS, Noh MM, Jeffree MS, Ali RA. SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease-( covid-19). Bosn J Basic Med Sci. 2020;20(3):283-92. DOI: https://doi.org/10.17305/bjbms.2020.4860
dc.relation/*ref*/Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L. Nervous system involvement after infection with covid-19 and other coronaviruses. Brain Behav Immun. 2020;87:18-22. DOI: https://doi.org/10.1016/j.bbi.2020.03.031
dc.relation/*ref*/Bridwell R, Long B GM. Neurologic complications of covid-19. Am J Emerg Med. 2020;38(7):1-5. DOI: https://doi.org/10.1016/j.ajem.2020.05.024
dc.relation/*ref*/Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, Sánchez-Larsen Á, Layos-Romero A, García-García J, et al. Neurologic manifestations in hospitalized patients with covid-19: The albacovid registry. Neurology. 2020;10:1212.
dc.relation/*ref*/Román G, Spencer P, Reis J, Buguet A, Faris M, Katrak S, et al. The Neurology of covid-19 Revisited: A Proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to Implement International Neurological Registries. J Neurol Sci. 2020;414(4):116884. DOI: https://doi.org/10.1016/j.jns.2020.116884
dc.relation/*ref*/Pryce-Roberts A, Talaei M, Robertson N. Neurological complications of COVID-19: a preliminary review. J Neurol. 2020;267(6):1870-3. DOI: https://doi.org/10.1007/s00415-020-09941-x
dc.relation/*ref*/Moshayedi P, Ryan TE, Mejia LLP, Nour M, Liebeskind DS. Triage of Acute Ischemic Stroke in Confirmed co- vid-19: Large Vessel Occlusion Associated With Coro- navirus Infection. Front Neurol. 2020;11(April):10-2. DOI: https://doi.org/10.3389/fneur.2020.00353
dc.relation/*ref*/Spence J, de Freitas G., Pettigrew L, Ay H, Liebeskind D, Kase C, et al. Mechanisms of Stroke in covid-19. Cerebrovasc Dis. 2020;20(7):1-8.
dc.relation/*ref*/Oxley TJ, Mocco J, Majidi S et al. Large-Vessel Stroke as a Presenting Feature of covid-19 in the Young. N Engl J Med. 2020;382(20):60. DOI: https://doi.org/10.1056/NEJMc2009787
dc.relation/*ref*/Fan H, Tang X, Song Y, Liu P, Chen Y. Influence of covid-19 on cerebrovascular disease and its possible mechanism. Neuropsychiatr Dis Treat. 2020;16:1359- 67. DOI: https://doi.org/10.2147/NDT.S251173
dc.relation/*ref*/Sheraton M, Deo N, Kashyap R, Surani S. A Review of Neurological Complications of covid-19. Cureus. 2020;2(5):8192. DOI: https://doi.org/10.7759/cureus.8192
dc.relation/*ref*/Jin H, Hong C, Chen S, Zhou Y, Wang Y, Mao L, et al. Consensus for Prevention and management of coronavirus disease 2019 (covid-19) for neurologists. Stroke Vasc Neurol. 2020;5(2):146-51. DOI: https://doi.org/10.1136/svn-2020-000382
dc.relation/*ref*/Divani A, Andalib S, Napoli M, Lattanzi S, Hus- sain M, Mccullough L, et al. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights. J Stroke Cerebrovasc Dis. 2020;29(8):104941. DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104941
dc.relation/*ref*/Montalvan V, Lee J, Bueso T, De Toledo J, Rivas K. Neurological manifestations of covid-19 and other coronavirus infections: A systematic review. Clin Neurol Neurosurg. 2020;194(7):105921. DOI: https://doi.org/10.1016/j.clineuro.2020.105921
dc.relation/*ref*/aha/asa Stroke Council Leadership. Temporary Emergency Guidance to us Stroke Centers During the Coronavirus Disease 2019 (covid-19) Pandemic: On Behalf of the American Heart Association/Ame- rican Stroke Association Stroke Council Leadership. Stroke. 2020;51(6):1910-2. DOI: https://doi.org/10.1161/STROKEAHA.120.030023
dc.relation/*ref*/Han Y, Zeng H, Jiang H, Yang Y, Yuan Z, Cheng X, et al. csc Expert Consensus on Principles of Clinical Manage- ment of Patients with Severe Emergent Cardiovascular Diseases during the covid-19 Epidemic. Circulation. 2020;141(20):810-6. DOI: https://doi.org/10.1161/CIRCULATIONAHA.120.047011
dc.relation/*ref*/Dafer R, Osteraas N, Biller J. Acute Stroke Care in the Coronavirus Disease 2019 Pandemic. J Stroke Cerebrovasc Dis. 2020;29(7):104881. DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104881
dc.relation/*ref*/Meyer D, Meyer B, Rapp K, Modir R, Agrawal K, Hailey L, et al. A Stroke Care Model at an Academic, Comprehensive Stroke Center During the 2020 covid-19 Pandemic. J Stroke Cerebrovasc Dis. 2020; 29(8):104927. DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104927
dc.relation/*ref*/De Silva D, Tan I, Thilarajah S. A protocol for acute stroke unit care during the covid-19 pandemic. J Stroke Cerebrovasc Dis. 2020;29(9):105009. DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105009
dc.relation/*ref*/Sedaghat Z, Karimi N. Guillain Barre syndrome associated with covid-19 infection: A case report. J Clin Neurosci. 2020;76(6):233-5. DOI: https://doi.org/10.1016/j.jocn.2020.04.062
dc.relation/*ref*/Toscano G, Palmerini F, Ravaglia S et al. Guillain-Barré Syndrome Associated with sars-cov-2. N Engl J Med. 2020;382(26):2574-6. DOI: https://doi.org/10.1056/NEJMc2009191
dc.relation/*ref*/Alberti P, Beretta S, Piatti M, Karantzoulis A, Piat- ti ML, Santoro P, et al. Guillain-Barré syndrome reLated to covid-19 infection. Neurol Neuroimmunol NeuroInflammation. 2020;7(4):741. DOI: https://doi.org/10.1212/NXI.0000000000000741
dc.relation/*ref*/Chan M, Han S, Kelly S, Tamimi M, Giglio B, Lewis A. A case series of Guillain-Barré Syndrome Following covid-19 Infection in New York. Neurol Clin Pract. 2020;10.1212/CP. DOI: https://doi.org/10.1212/CPJ.0000000000000880
dc.relation/*ref*/Gutiérrez-Ortiz C, Méndez A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, Gordo-Mañas R, et al. Miller Fisher Syndrome and polyneuritis cranialis in covid-19. Neurology. 2020;95(5):601-5. DOI: https://doi.org/10.1212/WNL.0000000000009619
dc.relation/*ref*/Manganotti P, Pesavento V, Buoite Stella A, Bonzi L, Campagnolo E, Bellavita G, et al. Miller Fisher syndrome diagnosis and treatment in a patient with sars-cov-2. J Neurovirol. 2020;1-2. DOI: https://doi.org/10.1007/s13365-020-00858-9
dc.relation/*ref*/Casas E, Barbosa A, Rubio-García E, Cebrián J, Díaz-Pérez C, de la Fuente E, et al. Isolated peripheral facial paralysis in a patient with covid-19. Rev Neurol. 2020;71(1):40-1. DOI: https://doi.org/10.33588/rn.7101.2020229
dc.relation/*ref*/Kobylecki C, Jones T, Lim C, Miller C, Thomson A. Phenomenology and outcomes of in‐patients with Parkinson's disease during covid-19 pandemic. Mov Di- sord. 2020;35(8):1295-6. DOI: https://doi.org/10.1002/mds.28205
dc.relation/*ref*/Zhang J, Hu W, Chen H, Meng F, Li L, Okun MS. Implementation of a Novel Bluetooth Technology for Remote Deep Brain Stimulation Programming: The Pre- and Post-covid-19 Beijing Experience. Mov Disord. 2020;35(6):909-10. DOI: https://doi.org/10.1002/mds.28098
dc.relation/*ref*/Goetz CG, Stebbins GT, Luo S. Movement Disorder Society-Unified Parkinson's Disease Rating Scale Use in the covid-19 Era. Mov Disord. 2020;35(6):911. DOI: https://doi.org/10.1002/mds.28094
dc.relation/*ref*/Salari M, Zali A, Ashrafi F, Etemadifar M, Sharma S, Hajizadeh N, et al. Incidence of Anxiety in Parkinson's Disease During the Coronavirus Disease (covid-19) Pandemic. Mov Disord. 2020;35(7):1095-6. DOI: https://doi.org/10.1002/mds.28116
dc.relation/*ref*/Vollono C, Rollo E, Romozzi M, Frisullo G, Servidei S, Borghetti A, et al. Focal Status Eepilepticus as Unique Clinical Feature of covid-19: a Case Report. Seizure. 2020;78:109-12. DOI: https://doi.org/10.1016/j.seizure.2020.04.009
dc.relation/*ref*/Elgamasy S, Kamel MG, Ghozy S, Khalil A, Morra ME, Islam sms. First Case of Focal Epilepsy Associated with SARS Coronavirus-2. J Med Virol. DOI: https://doi.org/10.1002/jmv.26113
dc.relation/*ref*/Libbey JE, Kirkman NJ, Smith MCP, Tanaka T, Wilcox KS, White HS, et al. Seizures Following Picornavirus Infection. Epilepsia. 2008;49(6):1066-74. DOI: https://doi.org/10.1111/j.1528-1167.2008.01535.x
dc.relation/*ref*/Hepburn M, Mullaguri N, George P, Hantus S, Punia V, Bhimraj A, et al. Acute Symptomatic Seizures in Critically Ill Patients with covid-19: Is There an Association? Neurocrit Care. 2020;1-5. DOI: https://doi.org/10.1007/s12028-020-01006-1
dc.relation/*ref*/Cabezudo-García P, Ciano-Petersen NL, Mena-Váz- quez N, Pons-Pons G, Castro-Sánchez MV, Serra- no-Castro PJ. Incidence and Case Fatality Rate of covid-19 in Patients with Active Epilepsy. Neurology. 2020;10.1212/WN. DOI: https://doi.org/10.1212/WNL.0000000000010033
dc.relation/*ref*/Lu L, Xiong W, Liu D, Liu J, Yang D, Li N, et al. New Onset Acute Symptomatic Seizure and Risk Factors in Coronavirus Disease 2019: A Retrospective Multicenter Study. Epilepsia. 2020;61(6):49-e53. DOI: https://doi.org/10.1111/epi.16524
dc.relation/*ref*/Kuroda N. Epilepsy and COVID-19: Associations and Important Considerations. Epilepsy Behav. 2020;108:107122. DOI: https://doi.org/10.1016/j.yebeh.2020.107122
dc.relation/*ref*/Pati S, Houston T. Assessing the Risk of Seizures with Chloroquine or Hydroxychloroquine Therapy for covid-19 in Persons with Epilepsy. Epilepsy Res. 2020;165:106399. DOI: https://doi.org/10.1016/j.eplepsyres.2020.106399
dc.relation/*ref*/Kwan P, Arzimanoglou A, Berg A, Brodie M, Hauser W, Mathern G, et al. Definition of Drug Resistant Epilepsy: Consensus Proposal by the ad hoc Task Force of the ilae Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069-77. DOI: https://doi.org/10.1111/j.1528-1167.2009.02397.x
dc.relation/*ref*/Olesen J. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. DOI: https://doi.org/10.1177/0333102417738202
dc.relation/*ref*/Yachou Y, El Idrissi A, Belapasov V, Ait S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in covid-19 patients. Neurol Sci. 2020;1-13. DOI: https://doi.org/10.1007/s10072-020-04575-3
dc.relation/*ref*/Moore JB, June CH. Cytokine release syndrome in severe covid-19. Science (80-). 2020;368(6490):473-4. DOI: https://doi.org/10.1126/science.abb8925
dc.relation/*ref*/Benemei S, Dussor G. trp channels and migraine: Recent developments and new therapeutic opportunities. Pharmaceuticals. 2019;12(2):1-17. DOI: https://doi.org/10.3390/ph12020054
dc.relation/*ref*/Baig A, Khaleeq A, Ali U, Syeda H. Evidence of the covid-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. acs Chem Neurosci. 2020;11(7):995-8. DOI: https://doi.org/10.1021/acschemneuro.0c00122
dc.relation/*ref*/Bolay H, Gül A, Baykan B. covid-19 is a Real Headache! Headache. 2020;10.1111/he. DOI: https://doi.org/10.1111/head.13856
dc.relation/*ref*/Borges do Nascimento IJ, Cacic N, Abdulazeem HM, von Groote TC, Jayarajah U, Weerasekara I, et al. No- vel Coronavirus Infection (covid-19) in Humans: A Scoping Review and Meta-Analysis. J Clin Med. 2020;9(4):941. DOI: https://doi.org/10.3390/jcm9040941
dc.relation/*ref*/Whittaker A, Anson M, Harky A. Neurological Mani- festations of covid-19: A Systematic Review and Current Update. Acta Neurol Scand. 2020;142(1):14-22. DOI: https://doi.org/10.1111/ane.13266
dc.relation/*ref*/Maassenvandenbrink A, De Vries T, Danser AHJ. Headache Medication and the covid-19 Pandemic. J Headache Pain. 2020;21(1):1-4. DOI: https://doi.org/10.1186/s10194-020-01106-5
dc.relation/*ref*/Katal S, Balakrishnan S, Gholamrezanezhad A. Neuroimaging and Neurologic Findings in covid-19 and Other Coronavirus Infections: A Systematic Review in 116 Patients. J Neuroradiol. 2020;S0150- 9861(20):30204-2.
dc.relation/*ref*/Kremer S, Lersy F, Anheim M, Merdji H, Schenck M, Oesterlé H, et al. Neurologic and Neuroimaging Findings in covid-19 Patients: A Retrospective Multicenter Study. Neurology. 2020;10.1212/WN.
dc.relation/*ref*/Carod-Artal FJ. Neurological complications of coronavirus and covid-19. Rev Neurol. 2020;70(9):311- 22. DOI: https://doi.org/10.33588/rn.7009.2020179
dc.relation/*ref*/Moriguchi T, Harii N, Goto J, Harada D, Sugawara H. Since January 2020 Elsevier has created a covid-19 resource centre with free information in English and Mandarin on the novel coronavirus covid-19. The covid-19 resource centre is hosted on Elsevier Connect, the company' s public news and information. 2020;(en).
dc.relation/*ref*/Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S GB. covid-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology. 2020;296(2):119-20. DOI: https://doi.org/10.1148/radiol.2020201187
dc.rightsDerechos de autor 2021 Revista Medes-ES
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0es-ES
dc.sourceRevista Med; Vol. 29 No. 1 (2021): january - june; 57-76en-US
dc.sourceRevista Med; Vol. 29 Núm. 1 (2021): enero - junio; 57-76es-ES
dc.source1909-7700
dc.source0121-5256
dc.titleNeurological manifestations due to COVID-19. Case report at Hospital Militar Central Bogotá, Colombia, and literature reviewen-US
dc.titleManifestaciones neurológicas por COVID-19. Reporte de casos en Hospital Militar Central Bogotá, Colombia, y revisión de la literaturaes-ES
dc.titleManifestações neurológicas pela COVID-19. Relato de casos no Hospital Militar Central Bogotá, Colômbia, e revisão da literaturapt-BR
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


Este ítem pertenece a la siguiente institución